Efg Asset Management (North America) Corp. Protagonist Therapeutics, Inc Transaction History
Efg Asset Management (North America) Corp.
- $580 Million
- Q1 2025
A detailed history of Efg Asset Management (North America) Corp. transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 71,134 shares of PTGX stock, worth $3.17 Million. This represents 0.59% of its overall portfolio holdings.
Number of Shares
71,134Holding current value
$3.17 Million% of portfolio
0.59%Shares
1 transactions
Others Institutions Holding PTGX
# of Institutions
299Shares Held
61.4MCall Options Held
1.01MPut Options Held
555K-
Farallon Capital Management LLC San Francisco, CA6.11MShares$272 Million1.7% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$257 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.72MShares$255 Million4.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.28MShares$191 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3MShares$134 Million5.07% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $2.19B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...